Table 2.
Primary and secondary outcomes.
| Outcome | Retrospective (n = 32) |
Prospective (n = 29) |
Overall (n = 61) |
P (χ2test) |
|---|---|---|---|---|
| Favorable neurological performance | ||||
| In-hospital | 16 (50.00%) | 21 (72.41%) | 37 (60.66%) | 0.074 |
| Follow-upa | 15 (46.88%) | 19 (65.52%) | 34 (55.74%) | |
| Survival | ||||
| Hospital discharge | 17 (53.12%) | 21 (72.41%) | 38 (62.30%) | 0.121 |
| Follow-upa | 16 (50.00%) | 20 (68.97%) | 36 (59.02%) | |
a
Median ± SEM (25th, 75th percentiles). Retrospective: 48.5 ± 10.5 (27.0, 68.7) months. Prospective: 5 ± 1.8 (3.5, 7.5) months.